产品介绍: Bucillamine (SA96) 是一种口服有效的巯基供体和抗氧化剂 (antioxidant)的成分。Bucillamine 也是一种抗风湿药 (antirheumatic agent)的主要成分,具有抗血管生成 (antiangiogenic) 的特性。Bucillamine 对高危器官移植的缺血再灌注 (I/R) 损伤有保护作用。Bucillamine 抑制 VEGF 的产生。Bucillamine 可用于脉络膜新生血管性疾病 (CNV) 和类风湿关节炎 (RA) 的研究。 Bucillamine is an antirheumatic agent.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Bucillamine
CAS number:65002-17-7 molecular formula:C7H13NO3S2
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | Bucilant | bucillamine | N-(2-Mercaptoisobutyryl)-L-cysteine | Thiobutarit | BDBM50406934 | CHEBI:31312 | Q-101254 | Bucilant (TN) | (2R)-3-mercapto-2-[(2-mercapto-2-methyl-1-oxopropyl)amino]propanoic acid | NCGC00182062-02 | AKOS015895462 | DE019; SA96;T | ||
| CAS number | 65002-17-7 | molecular formula | C7H13NO3S2 |
| molecular weight | 223.31 g/mol | Exact mass | ≥96% |
| PSA | 68.400 Ų | logp | 0.4 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
RTECS:
HA2420000
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





